<DOC>
	<DOCNO>NCT01834053</DOCNO>
	<brief_summary>This study Single arm , Single Centre trial check Safety Efficacy Bone Marrow Derived Autologous mononuclear cell { MNC } ( 100 Million per dose ) .trial conduct 36 month patient diabetes Mellitus India , Primary outcome measure Improvement cognitive Psychiatric Symptoms Improvement Jerky , random , Uncontrollable Movements call Chorea .</brief_summary>
	<brief_title>Safety Efficacy Bone Marrow Derived MNCs Treatment Cells Treatment Hunting Tons Chorea .</brief_title>
	<detailed_description>This study Single arm , Single Centre trial study Safety Efficacy Bone Marrow Derived Autologous mononuclear cell ( MNCs ) , conduct 36 month patient diabetes Mellitus India , Primary outcome measure Improvement cognitive Psychiatric Symptoms Improvement Jerky , random , Uncontrollable Movements call Chorea .</detailed_description>
	<mesh_term>Huntington Disease</mesh_term>
	<criteria>Patient suffer Hunting ton Chorea , Hunting ton chorea commonly become noticeable age 35 44 Willingness undergo Bone Marrow derive Autologous cell Therapy . Ability comprehend explain protocol thereafter give informed consent well sign require Informed Consent form ( ICF ) study . Ability willingness regular visit hospital protocol procedure follow Patient History Immunodeficiency HIV+ , Hepatitis B virus ( HBV ) History Life threaten allergic immune Mediated Reaction . site bone marrow aspiration potentially limiting Procedure . alcohol drug abuse / dependence . Severe skin infection . Haemodynamically unstable . =subject primary secondary diabetes , Insulin dependence . Neurological disease cause autoimmune genetic cause . patient suffer peripheral muscular dystrophy .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Huntington Disease , stem cell therapy</keyword>
</DOC>